JPRN-jRCT2080223788已完成2 期
Single dose pharmacokinetic study of HP-3060 in pediatric patients with allergic rhinitis (2)
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients who a diagnosis of allergic rhinitis and symptoms of this condition.
排除标准
- •- Patients who have a history of hypersensitivity to any medicines.
- •- Patients who may be affected by blood sampling in the study following blood collection or bleeding within 4 weeks prior to study drug administration.
研究者
相似试验
未知
2 期
Single dose pharmacokinetic study of HP-3060Allergic rhinitisJPRN-jRCT2080223009Hisamitsu Pharmaceutical Co., Inc.
已完成
1 期
Pharmacokinetic study of HP-6050Healthy adult and elderlyJPRN-jRCT2031220536Inakura Hiroshi60
未知
1 期
Phase I/II study of HP-3060 in patients with allergic rhinitis.Allergic rhinitisJPRN-jRCT2080222141Hisamitsu Pharmaceutical Co., Inc.
已完成
1 期
A single-dose study of HP-6050Healthy adultJPRN-jRCT2031220092Inakura Hiroshi16
未知
2 期
Phase II clinical study in patients with Parkinson's disease.Parkinson's diseaseJPRN-jRCT2080221631Hisamitsu Pharmaceutical Co., Inc.